Tuesday - February 10, 2026
Dana-Farber Study Finds Dual Immunotherapy May Help Certain Patients with Advanced Non-Small Cell Lung Cancer Live Longer
January 20, 2026
BOSTON, Massachusetts, Jan. 20 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:

* * *

Dana-Farber Study Finds Dual Immunotherapy May Help Certain Patients with Advanced Non-Small Cell Lung Cancer Live Longer

*

Research Summary

Study Title : Dual Versus Single Checkpoint Inhibition in Advanced Non-Small Cell Lung Cancer: A Pooled Patient-Level Analysis of Six Randomized Trials
. . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products